![](/img/cover-not-exists.png)
Is Peg-interferon plus ribavirin a cost-effective therapy, and if so, what is the most efficient way to use this therapy in naive patients with chronic hepatitis C?
Maria Buti, Miguel A. Casado, Montserrat Medina, Leslie Fosbrook, Rafael EstebanVolume:
36
Year:
2002
Language:
english
DOI:
10.1016/s0168-8278(02)80357-9
File:
PDF, 105 KB
english, 2002